Statistics
Publications
1
Citations
34
H-Index
1
Active since
2023
Affiliations
Tris Pharma (United States)(Current)
Jiyoung E. Choi is an author at Tris Pharma (United States) specializing in programmed death-1 inhibition, programmed cell death protein 1 inhibitors, and combination immunotherapy.
Publications per year
2023–2023
1
1